Intravenous CDP870, a PEGylated Fab′ fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: An exploratory study
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Intravenous CDP870, a PEGylated Fab′ fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: An exploratory study'. Together they form a unique fingerprint.
Nursing and Health Professions
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science